These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 16987710

  • 1. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T, Galatowicz G, Bunce C, Calder V, Lynn WA, Lightman S.
    Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
    [Abstract] [Full Text] [Related]

  • 2. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN, Shang H, Jiang YJ, Liu J, Dai D, Diao YY, Geng WQ, Jin X, Wang YN.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1966-71. PubMed ID: 17199940
    [Abstract] [Full Text] [Related]

  • 3. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF, Price P, French MA.
    HIV Med; 2005 Jul 05; 6(4):278-83. PubMed ID: 16011533
    [Abstract] [Full Text] [Related]

  • 4. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M, Swiss HIV Cohort Study Group.
    Arch Intern Med; 2003 Oct 13; 163(18):2187-95. PubMed ID: 14557216
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
    Dai Y, Qiu ZF, Li TS, Han Y, Zuo LY, Xie J, Ma XJ, Liu ZY, Wang AX.
    Chin Med J (Engl); 2006 Oct 20; 119(20):1677-82. PubMed ID: 17097013
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945
    [Abstract] [Full Text] [Related]

  • 8. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F, Thiébaut R, Chêne G, Neau D, Pellegrin JL, Mercié P, Beylot J, Dabis F, Salamon R, Morlat P, Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA).
    HIV Med; 2005 May 15; 6(3):198-205. PubMed ID: 15876287
    [Abstract] [Full Text] [Related]

  • 9. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
    Nemes E, Lugli E, Nasi M, Ferraresi R, Pinti M, Bugarini R, Borghi V, Prati F, Esposito R, Cossarizza A, Mussini C.
    AIDS; 2006 Oct 24; 20(16):2021-32. PubMed ID: 17053348
    [Abstract] [Full Text] [Related]

  • 10. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S, Toma E, Cordeiro P, Ahmad R, Morisset R, Menezes J.
    J Med Virol; 2006 Apr 24; 78(4):431-9. PubMed ID: 16482539
    [Abstract] [Full Text] [Related]

  • 11. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 24; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

  • 12. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
    Beran O, Holub M, Spála J, Kalanin J, Stanková M.
    Acta Virol; 2003 Jun 24; 47(2):121-4. PubMed ID: 14524479
    [Abstract] [Full Text] [Related]

  • 13. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.
    Carcelain G, Tubiana R, Samri A, Calvez V, Delaugerre C, Agut H, Katlama C, Autran B.
    J Virol; 2001 Jan 24; 75(1):234-41. PubMed ID: 11119593
    [Abstract] [Full Text] [Related]

  • 14. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F, Mezzaroma I.
    Clin Infect Dis; 2008 Jun 15; 46(12):1902-10. PubMed ID: 18462177
    [Abstract] [Full Text] [Related]

  • 15. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM, Price P, Lee S, Almeida CA, Stone SF, James I, French MA.
    HIV Med; 2004 Nov 15; 5(6):407-14. PubMed ID: 15544692
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM, López M, Lozano S, González-Lahoz J, Soriano V.
    J Infect Dis; 2008 Nov 15; 198(10):1466-73. PubMed ID: 18847371
    [Abstract] [Full Text] [Related]

  • 17. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
    Tamarit A, Alberola J, Mir A, Benet I, Mira JV, Muñoz C, Galindo MJ, Navarro D.
    J Clin Virol; 2004 Apr 15; 29(4):308-14. PubMed ID: 15018860
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM, Lima PG, Filho RG, Hygino J, Milczanowski SF, Andrade AF, Lauria C, Brindeiro R, Tanuri A, Bento CA.
    AIDS; 2007 Aug 20; 21(13):1763-70. PubMed ID: 17690575
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G, Gori A, Casabianca A, Magnani M, Franzetti F, Clerici M, Perno CF, Monforte Ad, Galli M, Meroni L.
    AIDS; 2006 Aug 22; 20(13):1727-36. PubMed ID: 16931937
    [Abstract] [Full Text] [Related]

  • 20. T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy.
    Dyrhol-Riise AM, Ohlsson M, Skarstein K, Nygaard SJ, Olofsson J, Jonsson R, Asjö B.
    Clin Immunol; 2001 Nov 22; 101(2):180-91. PubMed ID: 11683577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.